About Insightra
Insightra is a Healthcare company based in Irvine (United States) founded in 2001. It operates as an intra-aortic balloon catheters are developed for cardiology surgeries. Insightra has raised $19.96 million across 6 funding rounds from investors including Tekla Capital Management and Baird Capital. Its Indian entity Interventional Cardiology Devices Disposables & Innovations Systems Private Limited reported revenue of ₹1.00 Cr. Insightra offers products and services including Ultra 7FR IAB Catheter Kit. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include InterValve, Laguna Tech USA, TNMI, Hybernia Medical and AR Baltic Medical and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Insightra was founded in 2001 and is based in Irvine, United States. Medical devices for cardiology interventions are developed and offered by the company, including intra-aortic balloon catheters, wire insertion tools, balloon pump catheters, surgical retractors, stents, and hernia systems. Operations focus on tools used in surgical procedures to support cardiovascular treatments.
- Headquarters Irvine, United States
- SectorsHealthcare
- Website insightra.com
- Social LinkedIn
- Legal Name Interventional Cardiology Devices Disposables & Innovations Systems Private Limited
- Date of Incorporation 25 Sep, 2007
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1.00 Cr
FY 2024 · +11% YoY
- Net Profit₹30.2 Lakh
FY 2024 · 30% margin
- EBITDA₹40.9 Lakh
FY 2024 · 41% margin
- Total Equity Funding$19.96M (USD)
in 6 rounds
- Latest Funding Round$5M (USD), Series D
Aug 2015
- InvestorsTekla Capital Management
& 1 more
Associated legal entities of Insightra
Insightra operates through Interventional Cardiology Devices Disposables & Innovations Systems Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Interventional Cardiology Devices Disposables & Innovations Systems Private Limited CIN U33129MH2007PTC174476 | Active | 25 Sep 2007 | Mumbai, Maharashtra | ₹1.0 Cr | – | 2 | View details |
Products & Services of Insightra
Insightra offers a comprehensive portfolio of products and services, including Ultra 7FR IAB Catheter Kit.
Supports heart function with balloon catheter for cardiovascular interventions.
Funding Insights of Insightra
Insightra has successfully raised a total of $19.96M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $5 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.96M
- Total Rounds 6
- Last Round Series D — $5M
- Investors Count 2
All 6 funding rounds of Insightra with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2015 | $5M | Series D | – | – | – |
| Jun 2015 | $2.84M | Series D | – | – | – |
| Dec 2014 | $6.13M | Series C | – | – | – |
| May 2014 | $6M | Series C | – | – | – |
| Oct 2013 | – | Series C | – | Baird Capital, Tekla Capital Management | – |
| Apr 2012 | – | Series B | – | – | – |
2 investors in total: 2 institutional.
Investors in Insightra
Insightra has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Tekla Capital Management and Baird Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Global private equity and venture capital investments in B2B Tech & Services companies. | – | bairdcapital.com | - | |
Investment advisory services are provided to financial clients. | 1986 | teklacap.com | Boston, United States |
Investor details for Insightra
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Interventional Cardiology Devices Disposables & Innovations Systems Private Limited (Insightra)
Interventional Cardiology Devices Disposables & Innovations Systems Private Limited is the primary company behind Insightra. The board of Interventional Cardiology Devices Disposables & Innovations Systems Private Limited currently have 2 directors; the longest-serving is Laxmikant Gunanath Khanolkar, appointed in 2007. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Laxmikant Gunanath Khanolkar DIN 01225911 | Director | 25 Sep 2007 | 19 yrs | Interventional Cardiology Devices Disposables & Innovations Systems Private Limited |
| Partha Laxmikant Khanolkar DIN 03606289 | Director | 18 Jun 2019 | 7 yrs 4 mo | Interventional Cardiology Devices Disposables & Innovations Systems Private Limited |
Financials of Insightra
Figures of Interventional Cardiology Devices Disposables & Innovations Systems Private Limited, the primary company behind Insightra, for FY 2024. Revenue was ₹1.00 Cr (+11% year on year). Net profit was ₹30.2 Lakh (30% margin). EBITDA was ₹40.9 Lakh (41% margin). Revenue has grown at a compounded annual rate of +8% over three years and +12% over five years.
- ₹1.00 CrRevenue · FY 2024 · +11% YoY
- ₹30.2 LakhNet profit · 30% margin
- ₹40.9 LakhEBITDA · 41% margin
- ₹1.3 LakhPaid-up capital
- +8%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Interventional Cardiology Devices Disposables & Innovations Systems Private Limited are on its company page.
Detailed financial statements for Insightra
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Insightra
3 dated milestones of Insightra across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Insightra is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $5.0M.
Competitors of Insightra
Insightra has 9 listed competitors in our database, 4 of them funded. They include InterValve, Laguna Tech USA, TNMI, Hybernia Medical and AR Baltic Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| intervalveinc.com | 2008 | Minneapolis, United States | $11.13M | – | Aortic valvuloplasty balloons are developed for valve stenosis treatment. | |
| lagunatechmed.com | 2021 | Irvine, United States | – | – | Heart valve systems are developed to treat valve regurgitation. | |
| tn-mi.com | 2001 | Clarksville, United States | – | – | Medical devices are developed and manufactured for surgical procedures. | |
| hyberniamedical.com | 2006 | Uniondale, United States | $3.71M | – | Solutions for acute ischemic stroke treatment are developed. | |
| arbalticmed.com | 2019 | Vilnius, Lithuania | – | – | Manufactures medical devices like drug-coated balloons for healthcare applications. | |
| lutonix.com | 2007 | Minneapolis, United States | $35M | – | Drug-coated balloon catheters are developed for vascular lesion treatments. | |
| anchorballoon.com | 2019 | Kalamazoo, United States | – | – | Creates innovative medical devices for cardiovascular and interventional procedures. | |
| synapticmed.com | 2005 | Lake Forest, United States | $60M | – | Medical devices for cardiac arrhythmias and cardiovascular diseases are developed. | |
| hicicarescience.com | 2019 | Mountain View, United States | – | – | Develops innovative interventional medical devices for treating special and complex lesions. |
Detailed competitors of Insightra
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Insightra (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Insightra
Complete news archive for Insightra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Insightra
Insightra was founded in 2001 and raised its 1st funding round 11 years after it was founded.
Insightra is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Insightra is a funded company, having raised a total of $19.96M across 6 funding rounds to date.
The primary company behind Insightra, Interventional Cardiology Devices Disposables & Innovations Systems Private Limited, reported revenue of ₹1.00 Cr for FY 2024, up 11% year on year.
Insightra was founded in 2001 and is based in Irvine, United States. Medical devices for cardiology interventions are developed and offered by the company, including intra-aortic balloon catheters, wire insertion tools, balloon pump catheters, surgical retractors, stents, and hernia systems. Operations focus on tools used in surgical procedures to support cardiovascular treatments.
Insightra's top competitors include InterValve, Synaptic Medical and Lutonix.
Insightra offers Ultra 7FR IAB Catheter Kit.
Insightra has 2 investors. Key investors include Tekla Capital Management, and Baird Capital.
Insightra operates through Interventional Cardiology Devices Disposables & Innovations Systems Private Limited.
The legal entities of Insightra currently have 2 directors, including Partha Laxmikant Khanolkar, Laxmikant Gunanath Khanolkar.